Drug Details
Therapeutic Class:
Central nervous system stimulants
Forms:
Extended-release capsules
Administration:
By mouth
Therapeutic Uses:
Attention deficit hyperactivity disorder (ADHD)
Controlled Status:
Schedule II controlled substance
Mydayis Drug Class
Mydayis (may-day-iss) is a central nervous system stimulant.
Mydayis Age Range
Mydayis is approved to treat ADHD symptoms in adults and children 13 years of age and older. Studies have found that children below 13 have a higher plasma exposure and more severe adverse effects.
SOCIAL